Sr. no. | Compound name (Abbreviation or Drug No.) | Score (S) | Nucleoprotein interacting residues |
---|---|---|---|
1 | [4-(5-bromanyl-3-methyl-pyridin-2-yl)piperazin- 1-yl]-[3-(2-chlorophenyl)-5-methyl-1,2-oxazol- 4-yl]methanone (OMS) | −24.9343 | ARG305, ASN309 |
2 | 1H-1,2,3-triazole-4-carboxamide (CBX) | −24.0769 | ARG305, ASN309 |
3 | 4-(2-chloro-4-nitrophenyl)piperazin-1-yl][3-(2-methoxyphenyl)-5-methyl-1,2-oxazol-4-yl]methanone (LGH) | −20.1668 | TYR52, GLY288 |
4 | (+)-(S)-2-(6-methoxynaphthalen-2-yl)-propanoic acid (Naproxen) | −16.7973 | ARG99, TYR52, SER376 |
5 | N-[4-chloranyl-5-[4-[[3-(2-methoxyphenyl)- 5-methyl-1,2-oxazol-4-yl]carbonyl]piperazin- 1-yl]-2-nitro-phenyl]thiophene-2-carboxamide (BMS-883559) | −16.0942 | ASN309, TYR52 |
6 | N-[4-chloranyl-5-[4-[[3-(2-methoxyphenyl)- 5-methyl-1,2-oxazol-4-yl]carbonyl]piperazin- 1-yl]-2-nitro-phenyl]pyridine-2-carboxamide (BMS-885838) | −8.5787 | SER50, SER376 |